The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
The main category of All News Articles.
You can use the search box below to find what you need.
[wd_asp id=1]
Cardano (ADA) continues to face bearish pressure as the cryptocurrency struggles to hold above the $0.49 support zone. The asset has maintained a downward trajectory for several weeks, with sellers dominating short-term momentum.
ADA currently trades around $0.534, remaining well below key moving averages. The persistent weakness reflects a broader market slowdown, as traders exit leveraged positions and sentiment cools across altcoins.
ADA has been trading below its 20, 50, 100, and 200-EMA levels, underscoring sustained bearish momentum. Each rebound attempt toward the $0.60–$0.65 …
Read The Full Article Cardano Price Prediction: ADA Price Faces Extended Weakness as Sellers Retain Control On Coin Edition.
November is Lung Cancer Awareness Month.
Lung cancer has been the leading cause of cancer death in the United States for many years. And it accounts for about 1 in 5 of all cancer deaths throughout the country. In fact, more Americans die from lung cancer than from breast, prostate and colon cancer combined.
The American Cancer Society (ACS) estimates that about 125,000 Americans will die from lung cancer this year — and about 60,000 of those will be women.
Smoking is still the leading cause of lung cancer, with the ACS estimating that tobacco use causes about 8 out of 10 lung cancer cases.
But there’s some good news, too. New cases of lung cancer have decreased by an average of 2.4% each year according to the latest statistics. And death rates have fallen an average of 4.2% per year over the last decade.
Anti-smoking efforts have helped many Americans quit smoking or, better yet, never start. And lung cancer treatments have become much more effective over time.
One more factor helps account for these improvements: lung cancer screening for people at high risk. Researchers estimate that lung cancer screening could reduce the lung cancer death rate by up to 20%.
Here are some answers to frequently asked questions about lung cancer screening.
In general, healthcare providers (HCPs) use screening tests to check for disease in healthy people who don’t have symptoms. The goal of screening is to find disease in its early stages, when treatment is most likely to be effective.
Lung cancer screening consists of a low-dose computed tomography (LDCT) scan of the lungs to look for lung cancer. This screening is currently recommended only for people at high risk for developing lung cancer.
To do this fast and painless test, you lie on a table that moves through a CT scanner to create clear images of your lungs.
The U.S. Preventive Services Task Force (USPSTF), a group that reviews scientific evidence to make patient-care recommendations, issued their most current recommendations in 2021. They recommend annual lung cancer screening for people who meet all of these requirements:
Compared to previous versions, the USPSTF’s current guidelines lowered the age to start screening from 55 to 50 and dropped the minimum number of pack years from 30 to 20.
These changes significantly increased the number of women — especially Black women — who are considered high risk for lung cancer.
The ACS also has a lung cancer screening guideline. It has one important difference from the USPSTF guideline: The ACS recommends yearly scans regardless of how long ago you stopped smoking.
Scientists who study tobacco use the term “pack year” to measure how much people have smoked over time. Multiply the number of cigarette packs you’ve smoked per day by the number of years you’ve smoked. That’s your pack year.
If you smoked two packs a day for 10 years, that’s 20 pack years, which means you’re eligible for lung cancer screening. If you smoked one pack a day for 15 years, that’s 15 pack years and below the 20 pack-year threshold for screening.
All screening tests carry the potential for both benefits and risks. That’s why you and your HCP should discuss your personal history and whether you should be screened for lung cancer. Shared decision-making means reviewing this information and creating a plan for your care together.
It’s important to note that smoking is currently the only risk factor for lung cancer that current screening guidelines consider.
Other potential causes of lung cancer like air pollution, radon exposure, secondhand smoke and genetic mutations are not included in today’s guidelines. Scientists are studying whether personalized screening approaches would identify more cases of lung cancer and potentially save more lives.
Read: How Shared Decision-Making Can Lead to Better Healthcare >>
The main benefit of lung cancer screening is the possibility of preventing death from lung cancer by catching it as soon as possible.
The American Lung Association (ALA) reports that lung cancer screening finds over half of lung cancer cases at an early stage when it’s more treatable.
One study found that only about 1 in 4 cases of lung cancers were found at an early stage without screening.
Lung cancer screening is unlikely to miss cancer, but it can happen. This is known as a false negative result.
Test results that suggest a person has cancer when they don’t are called false positives. The ALA estimates that about 12-14% of a person’s first lung cancer screenings will have a false positive. But only about 6% of repeat scans show false positives because HCPscompare scans over time to look for changes.
One potential con to lung cancer screening is that it may also identify cancers that may never have caused harm if left alone. Rarely, lung cancers grow slowly and without causing symptoms. But any kind of lung cancer diagnosis means your HCP will likely recommend treatment. And treating cancer that is unlikely to harm you is called overtreatment.
Screening with LDCT also involves the use of low-dose radiation to capture images of your body. Over time, this radiation can cause health problems. But it’s important to know that LDCTs use much less radiation than standard CT scans.
According to the ALA’s State of Lung Cancer Report, only 16% of eligible people received lung cancer screening in 2022.
Various real-world barriers may discourage some eligible people from getting lung cancer screening. For example, some high-risk people may not know that they are eligible for lung cancer screening.
Some longtime or former smokers may also hold back from screening because of anxiety that they might have lung cancer or worries about the stigma facing people with lung cancer, that they somehow deserve to be sick.
Transportation issues and physical access to LDCT screening centers can also keep people from getting screened. This is especially true for people who live in rural communities.
If you’re eligible for lung cancer screening, cost is unlikely to be a barrier. Medicare and most private insurance plans cover lung cancer screening for eligible people at 100%. That means you likely won’t have any out-of-pocket cost — just like mammograms and other screening tests. However, any additional testing and follow-up scans between screenings may have a cost, such as a co-pay or deductible.
This educational resource was created with support from Merck.
From Your Site Articles
Related Articles Around the Web
Natural Gas Price Trends Analysis in North America: Q3 2025 Break Down
Natural Gas Prices in United States:
As of Q3 2025, the average Natural Gas price in the USA is USD 3.81/MMBtu. Natural Gas prices are generally stable because of the seasonal fluctuations in demand described in the Natural Gas Price Index Report. Supply and demand are stable. Production has not been subject to major fluctuations, and U.S. prices are mostly stable according to Natural Gas Price Historical Data. Regional price variations are caused by differences in storage and heating demand.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/natural-gas-pricing-report/requestsample
Note: The analysis can be tailored to align with the customer’s specific needs.
Natural Gas Price Trends Analysis in APAC: Q3 2025 Overview
Natural Gas Prices in China:
During the third quarter of 2025, Natural Gas prices in China stayed at USD 2.72/MMBtu following the Natural Gas Price Index Report because the government supports renewable energy investments and imports LNG. Natural Gas prices stabilized according to historical data since earlier fluctuations occurred because industrial demand increased, and supply chains adjusted.
Regional Analysis: The price analysis can be extended to provide detailed natural gas price information for the following list of countries.
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.
Natural Gas Price Trends Analysis in MEA: Q3 2025 Overview
Natural Gas Prices in Saudi Arabia:
Saudi Arabia’s Natural Gas prices reflect stable domestic conditions and policies toward diversification of energy sources, maintaining its price of USD 2.75/MMBtu in Q3 2025. Production trends, particularly in the petrochemical sector which sustained consumption levels, also contributed to this price stability. Compared with Natural Gas Price Historical Data, the country has cheap extraction and investments in infrastructure that provide long-term stability.
Regional Analysis: The price analysis can be extended to provide detailed natural gas price information for the following list of countries.
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.
Natural Gas Price Trends in Europe: Q3 2025 Overview
Caustic Soda Prices in Germany:
In Germany, Natural Gas spot prices reached USD 11.6/MMBtu in Q3 2025, mainly due to a further decrease in imports, and increasing geopolitical pressure. The Natural Gas Price Index Report shows the continued dependence on foreign suppliers in the European markets. Natural Gas Price Historical Data shows gas prices in Germany during the last two years were more volatile than usual due to shortages on the global natural gas market.
Regional Analysis: The price analysis can be expanded to include detailed natural gas price data for a wide range of European countries:
such as Germany, France, the United Kingdom, Italy, Spain, Russia, Turkey, the Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, the Czech Republic, Portugal, and Greece, along with other European nations.
Natural Gas Price Trends Analysis in APAC: Q3 2025 Overview
Natural Gas Prices in India:
The average price for Natural Gas in India during Q3 2025 was USD 4.70/MMBtu. Market prices were stable because of Industrial and power sector demand. Import and domestic production balance were some of the factors mentioned in Natural Gas Price Index Report. Natural Gas Price Historical Data has seen its prices slowly increasing and this can be traced to India’s push towards cleaner energy and infrastructure development in the nation.
Regional Analysis: The price analysis can be extended to provide detailed natural gas price information for the following list of countries.
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.
Latest News & Recent Developments: Natural Gas Prices Trend, Index, History & Forecast
The global natural gas market in 2025 has experienced notable price adjustments across regions, influenced by seasonal patterns, production trends, and LNG trade dynamics. After an initial softening in mid-2025, the market faces renewed volatility as demand and supply fundamentals evolve.
Regional Price Insights
• United States: Natural gas prices averaged USD 3.81/MMBtu in September 2025, easing due to mild weather, strong shale output, and high storage levels. The U.S. Energy Information Administration (EIA) anticipates prices stabilizing around USD 3.42/MMBtu in 2025 and rising to USD 3.94/MMBtu in 2026 as winter demand recovers.
• Europe: Prices fell to around USD 11.6/MMBtu in Germany, supported by high storage levels and improved LNG supply chains. Robust imports and reduced industrial demand kept prices subdued.
• Asia-Pacific: In China and India, moderate consumption growth and steady LNG inflows stabilized prices near USD 2.72-4.70/MMBtu in Q3 2025. Mild seasonal conditions and strategic storage releases curtailed volatility.
• Middle East & Africa: Government-controlled pricing mechanisms in Saudi Arabia (~USD 2.75/MMBtu) ensured price stability, supported by strong domestic production and policy-driven resource allocation.
• Latin America: Prices remained steady as domestic production expanded in Brazil and Argentina, while LNG imports in Chile and Mexico balanced consumption fluctuations.
Key Market Drivers
• Ample Storage & Production: Elevated storage levels in the U.S. and Europe, alongside higher LNG terminal capacity, have eased supply concerns.
• Seasonal Moderation: Mild temperatures and stable industrial consumption slowed demand rebound.
• LNG Expansion: New LNG projects, coupled with improved trade efficiency, are gradually tightening the market.
• Regulatory Support: Policies promoting energy transition and industrial decarbonization continue to shape regional pricing.
Future Outlook (2025-2026)
• The EIA forecasts Henry Hub prices to range between USD 3.4-4.0/MMBtu, rising to USD 4.1-4.3/MMBtu by 2026 as global LNG exports and demand strengthen.
• European natural gas prices (TTF) are expected to average around USD 13-14/MMBtu in 2025, influenced by import competition and renewable energy integration.
• Asian markets remain steady through 2026, with consumption recovery in power generation and industrial sectors supporting moderate increases.
The market outlook suggests a balanced but sensitive pricing environment, where weather variability, LNG trade patterns, and policy-driven transitions will determine future price direction.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=22409&flag=C
Key Coverage:
• Market Analysis
• Market Breakup by Region
• Demand Supply Analysis by Type
• Demand Supply Analysis by Application
• Demand Supply Analysis of Raw Materials
• Price Analysis
o Spot Prices by Major Ports
o Price Breakup
o Price Trends by Region
o Factors influencing the Price Trends
• Market Drivers, Restraints, and Opportunities
• Competitive Landscape
• Recent Developments
• Global Event Analysis
How IMARC Pricing Database Can Help
The latest IMARC Group study, Natural Gas Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data 2025 Edition, presents a detailed analysis of Natural Gas price trend, offering key insights into global Natural Gas market dynamics. This report includes comprehensive price charts, which trace historical data and highlights major shifts in the market.
The analysis delves into the factors driving these trends, including raw material costs, production fluctuations, and geopolitical influences. Moreover, the report examines Natural Gas demand, illustrating how consumer behaviour and industrial needs affect overall market dynamics. By exploring the intricate relationship between supply and demand, the prices report uncovers critical factors influencing current and future prices.
About Us:
IMARC Group is a global management consulting firm that provides a comprehensive suite of services to support market entry and expansion efforts. The company offers detailed market assessments, feasibility studies, regulatory approvals and licensing support, and pricing analysis, including spot pricing and regional price trends. Its expertise spans demand-supply analysis alongside regional insights covering Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa. IMARC also specializes in competitive landscape evaluations, profiling key market players, and conducting research into market drivers, restraints, and opportunities. IMARC’s data-driven approach helps businesses navigate complex markets with precision and confidence.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales[@]imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
This release was published on openPR.
The British pound has spent the entire session on Tuesday falling apart as we are now well below the 1.31 level. The 1.31 level is an area that I had mentioned over the last couple of days to show signs of support, but it didn’t. So here we find ourselves going much lower. At this point, the 1.30 level seems to be almost assured.
I believe at this juncture we’re probably even looking at the 1.2750 level before it’s all said and done. That doesn’t mean that it’s going to be easy to get there, and it doesn’t necessarily mean that we are going to get there rapidly. But I would assume that we are in a situation where traders are going to continue to look at this as a market that, anytime you see any rally showing a bit of strength or even stability, you have to look at it through the prism of a market that, at the first signs of trouble, you have to be a seller of.
With that being said, I think you have a scenario where sooner or later we do see a big flush lower, but the candlestick on Tuesday may have been something that needs to be pushed back against at least in the short term. I look at the 1.32 level as a significant resistance barrier and most certainly the 1.3268 level, where the 200-day EMA currently sits, as a major resistance barrier. For what it’s worth, we’ve done nothing but fall for the most part since the September FOMC interest rate decision.
As a result, even though people are counting on the Federal Reserve to cut rates, it looks like there’s some serious fear out there, and we just collapsed through a major support level. If you are a little bit aggressive, you could look for a move down to 1.2750, maybe 1.28, based on the measured move of the consolidation that we just absolutely fell through. I’ve got no interest in buying the British pound. It looks like traders are betting on the Bank of England cutting rates soon, and therefore, I think the pound remains under pressure.
Ready to trade the Forex GBP/USD analysis and predictions? Here are the best forex trading platforms UK to choose from.
Christopher Lewis has been trading Forex and has over 20 years experience in financial markets. Chris has been a regular contributor to Daily Forex since the early days of the site. He writes about Forex for several online publications, including FX Empire, Investing.com, and his own site, aptly named The Trader Guy. Chris favours technical analysis methods to identify his trades and likes to trade equity indices and commodities as well as Forex. He favours a longer-term trading style, and his trades often last for days or weeks.
You may not be thinking about your cup of tea as you go over your pre-op plan with your health care provider. While herbal teas are natural, some can interact with medications and affect blood clotting, blood pressure and post-op healing. Jimmy Sung, M.D., shares, “The main reason we ask patients to stop all herbal supplements, including herbal tea, prior to surgery is to decrease the risk of bleeding and bruising. This is because many herbs have anticoagulant properties.”
That doesn’t mean you have to avoid all herbal teas. But, if you’re having surgery, there are some that should definitely be on your radar. “Most of the time, eating the real food or occasionally drinking a tea made with an herb would not result in a high-enough dose to affect a surgery,” says May Tom, RD. “It’s always better safe than sorry.”
So, which herbal teas might you want to avoid before and after surgery? To find out, we talked to doctors and dietitians. Here’s what they told us.
Ginger is known for helping with nausea and immunity. Tom notes, “It is popular during cold and flu season because it boosts the immune system, but it also can increase clotting time, so [it’s] best to avoid [it] for at least a week before surgery.” To date, few studies have actually shown that high doses of ginger slow blood clotting. So, more research is needed to confirm the extent of its effects. In the meantime, be sure to let your health care provider know if you are drinking ginger tea or taking a supplement containing ginger.
Ginkgo is a very popular supplement and is also available as a tea. “It can support brain health but should be avoided before and after surgery because of increased risk of bleeding,” says Tom. There are quite a few bioactive compounds in ginkgo, including kaempferol, quercetin, glycosides and ginkgolides. Its ginkgolides have been shown to adversely impact blood clotting and may promote bleeding.
Licorice root contains a compound called glycyrrhizin, which can cause irregular heartbeat and cardiac arrest if taken in large amounts. “In theory, licorice tea could raise blood pressure and cause surgery complications,” notes Tom.
Green tea is technically not an herbal tea, but it is a very popular tea and supplement. Reuben Chen, M.D., a physician and herbalist, notes that green tea’s catechins can increase the risk of bleeding. Green tea also interacts with some medications, including osteoporosis and cholesterol-lowering drugs.
Valerian root tea is commonly taken for sleep, although research on its effectiveness for promoting sleep or treating insomnia is inconclusive. Two of its constituents, valerinic acid and gamma-aminobutyric acid (GABA), may contribute to the sedative effects of the herb. Chen adds to avoid valerian after surgery, as its sedative effects can interact with narcotics. This may lead to excessive drowsiness and respiratory depression.
Chamomile tea is known for having an anticoagulant effect, notes Sung. It contains several bioactive compounds, especially coumarins, which may thin the blood. Right now, it’s unclear how much, if any, is safe. One recent small study found that drinking three cups of strong chamomile tea per day did not impact the time it took blood to clot. But it still makes sense to exercise caution. If you usually drink chamomile tea, check in with your health care professional to see if you should limit it around the time of your surgery.
Turmeric has been used for inflammation, pain and indigestion. Curcumin, perhaps the best-known active compound in turmeric, has anti-inflammatory properties. But it may also have antiplatelet effects. While research is still needed to determine if turmeric can cause post-operative bleeding, it couldn’t hurt to avoid it before and after surgery.
Before and after surgery, it’s natural to have a lot on your mind. But don’t forget to tell your health care provider about any herbal teas you usually drink. As innocent as herbal tea may seem, some herbal teas can cause dangerous complications if you drink them before or after surgery. “This revelation frequently arises during preoperative consultations, highlighting a common misconception that natural equates to safe,” says Chen. Herbal teas, like ginger, ginkgo biloba, licorice, valerian root, chamomile and turmeric tea, may lead to complications by interacting with medications or increasing bleeding risk or blood pressure. While it’s technically not an herbal tea, green tea may also act as a blood thinner.
Discussing your herbal intake with your health care team is important, as they can provide specific recommendations based on your health history and current supplement and medication routine. “The key is good communication with your surgeon and following their advice and instructions,” says Sung. Of course, not every surgery is planned in advance. Sung adds, “Herbal tea is not an absolute contraindication. If the surgery is urgent and necessary, it should proceed as long as the benefits outweigh the risks.”
XRP is showing signs of resilience as it holds $2 key support, sparking optimism among traders amid a volatile crypto market. Analysts are watching closely for potential rebounds.
The cryptocurrency has experienced notable swings in recent weeks, influenced by both market trends and regulatory developments. With Ripple’s recent initiatives and growing institutional interest, XRP may be positioned for a strong recovery toward the $5 mark.
XRP has recently stabilized near the $2 mark after a period of heightened volatility in the cryptocurrency market. Analysts and traders have noted that this level has acted as a strong horizontal support, preventing further declines and positioning the digital asset for a potential recovery. As of November 5, 2025, the XRP price today hovers around $2.22, following a rebound from its recent dip.
$XRP is expected to hold strong support around the $2 level. Source: Ali Martinez via X
Crypto analyst @ali_charts confirmed their October 31 prediction that XRP would find support at $2, a forecast that has now materialized. The chart from TradingView shows XRP’s daily price action on Binance, highlighting the $2 support level amid a broader downtrend from summer highs near $3.
“This support line has historically held during 20-30% corrections,” the analyst noted. “The current dip provides more clarity and may pave the way for a significant upside.”
In addition to technical support, Ripple XRP news highlights the launch of Ripple Prime, a new U.S.-focused crypto exchange that facilitates spot trading for institutional clients. The platform resulted from Ripple’s acquisition of Hidden Road and now enables over-the-counter (OTC) trading for large-scale investors.

Ripple Prime officially launches in the U.S., offering clients OTC spot trading for major digital assets and stablecoins, including $XRP and $RLUSD. Source: Ripple via X
Trading volumes on XRP have leaped, almost doubling to $8 billion—or about 6% of XRP’s circulating supply. Such liquidity may solidify xrp price prediction for 2025 by giving the token a basis to recover toward $5, some analysts say.
Although it has recently declined, technical indicators are showing a bullish scenario. XRP seems to form a bearish Bat harmonic pattern on the daily chart, hence a structure that normally forms in front of a potential reversal. The point C of this pattern, around $2.2285, has acted as a support, while the 200-day moving average, near $2.6235, is a key resistance.

The recent dip clarifies XRP’s weekly Elliott Wave pattern: Wave II is ending, and while a Wave 5 downside may form, it’s likely truncated and won’t break Wave 3’s low. Source: abdulahalkasid on TradingView
If XRP maintains its position above Point C and continues to gain momentum, it may move toward the potential reversal zone between $2.99 and $3.10. This setup indicates a near-term upside potential of approximately 34% from current levels, reinforcing the optimistic outlook for XRP price forecasts.
Analysts believe the price action of XRP will be determined by how the cryptocurrency behaves at its present support levels. If the token holds its current position above $2 and consolidates for a strong upward move, technical forecasts place the price closer to $5 in the next few months, backed by Elliott Wave patterns pointing toward the upside.

XRP was trading at around 2.25, down 1.13% in the last 24 hours at press time. Source: Brave New Coin
Failure to do so could mean a deeper pullback toward $1.60, though analysts consider this less probable given the prevailing market conditions. The neutral scenario is that XRP might consolidate between $2 and $2.50 before breaking out, establishing a very solid foundation for future gains. Analysts emphasize the importance of keeping a close eye on both technical indicators and macro market developments in light of ongoing regulatory updates that shape investor sentiment.
Other influences on XRP’s recent volatility have included regulatory updates, such as developments regarding the XRP SEC lawsuit. The resolution of some of these regulatory uncertainties has increased investor confidence and helped stabilize XRP.
This, combined with the possible approval of ETFs and continued institutional adoption, paints a bright outlook for XRP.
With XRP changing hands above the key support of $2 and growing institutional interest in the digital asset, the token seems well-positioned for a rally toward $5.
Market participants should continue to keep a close eye on the ongoing behavior of technical indicators, market sentiment, and regulatory developments that will materialize the price predictions of XRP for 2025.
Stream Finance, a decentralized finance (DeFi) protocol, has suspended all deposits and withdrawals after reportedly losing $93 million in an exploit involving one of its external asset managers. The company says it is assessing the full scope of the incident and has hired legal experts from Perkins Coie to investigate.
However, pending deposits will not be processed until further notice.
The issue began when Stream’s native stablecoin, Staked Stream USD (xUSD), lost its peg to the U.S. dollar. According to PeckShield, xUSD fell as low as $0.30 on Tuesday before partially recovering to the $0.37 range.
What’s with XRP?
This event quickly drew attention within the XRP community due to Stream’s connection with Midas, a platform that issues the mXRP liquid yield token on the XRP Ledger. Midas had previously held positions in xUSD through its mHYPER vault, which operates under MiCA-regulated structures in Germany.
While Midas claims to be operational and unaffected, traders have expressed concerns about indirect exposure through yield strategies tied to Stream’s assets.
Although the platform reiterated that withdrawals are functioning normally, several XRP community members described an atmosphere of “better safe than sorry” as users tested exit queues and liquidity buffers.
Looks like Midas was involved in the $93M loss of Stream earlier today. They claim they are unaffected.
Midas is known for also issuing mXRP on the XRP Ledger.
Word on the street recommends to withdraw. Better safe than sorry approach. pic.twitter.com/oD7XAWsI4t
Some advised users to withdraw from mHYPER as a precaution, citing potential clawback risks if legal action redistributes losses. Notable XRPL contributor Vet_X0 clarified that Midas’s exposure was limited to xUSD positions held days earlier and that normal redemption processing continues.
As of press time, the mXRP official dashboard shows a total value locked of about $25.55 million, with an advertised 10% annual yield.
Gold price rate today analysis, forecast and prediction indicate a steady recovery after recent declines. Spot gold rose 0.9% to $3,966.65 per ounce by 0713 GMT. The rise follows a fall of more than 1.5% on Tuesday when bullion touched its lowest level since October 30.
U.S. gold futures for December delivery increased by 0.4% to $3,975.30 per ounce. The U.S. dollar remained slightly below its three-month high recorded in the previous session.
According to Jigar Trivedi, senior currency analyst at Reliance Securities, the latest rise in gold prices reflects bargain buying and a general risk-off sentiment in global markets. This sentiment is supporting safe-haven demand for gold.
Asian stocks extended losses in early trading, following overnight declines on Wall Street. Investor concerns over stretched valuations continued to reduce confidence across markets.
Trivedi added that gold might face pressure if upcoming ADP data indicates stronger employment growth. A higher employment figure could reduce the likelihood of another rate cut this year. He also suggested that if the data exceeds expectations, gold could test levels near $3,900 per ounce.
The U.S. Federal Reserve recently cut interest rates. Fed Chair Jerome Powell suggested it might be the last rate reduction for this year. Following the announcement, the likelihood of another rate cut in December dropped from over 90% to around 69%, according to the CME FedWatch Tool. Officials at the Federal Reserve have shared mixed views on how to interpret current economic data, particularly as some U.S. government reports are delayed due to a potential government shutdown. The lack of new data is shifting investor attention to non-official sources, including the ADP National Employment Report expected later today.
Gold usually performs well when interest rates are low and economic uncertainty rises. The current market trend shows investors using gold as a hedge against potential risks and inflation concerns.
Despite today’s rise, gold remains below its recent record high of $4,381.21 reached on October 20. Since that peak, the metal has dropped by nearly 10%. Market participants remain cautious, balancing between expectations of further rate adjustments and signals from economic data releases.
Alongside gold, other precious metals also registered small gains. Spot silver increased by 1.1% to $47.61 per ounce. Platinum prices rose 0.4% to $1,541.17 per ounce. Palladium also moved higher by 0.5% to $1,398.28 per ounce.
Analysts note that these movements are linked to the broader recovery in commodity markets, as investors reposition portfolios amid shifting global financial conditions.
Based on the gold price rate today analysis, forecast and prediction, the near-term outlook for gold will depend on U.S. economic data, inflation expectations, and central bank policy signals. If inflation remains stable and employment data supports economic growth, gold may face downward pressure. However, if data reflects slowing growth or further policy easing, demand for gold could strengthen again.
Market experts continue to monitor the ADP report and upcoming Federal Reserve statements to gauge gold’s next direction. Until clarity emerges, price fluctuations are expected to remain within the current range.
Q2. What is the short-term outlook for gold price rate today analysis, forecast and prediction?
The short-term outlook depends on U.S. economic data and Federal Reserve policy. Prices may rise if economic growth slows or interest rate cuts continue.
slips as tech jitters overshadow stronger data. steadies post-BoJ minutes and ahead of .
The DAX, along with its European peers, is opening lower, extending losses for a second day. The negative start follows overnight deep declines in the US and Asia, as caution persists across global markets amid concerns about high valuations in AI-related and tech shares.
Valuation fears resurfaced this week on Wall Street after the record-breaking rally this year, driven by AI. However, warnings of a correction by the CEOs of major U.S. banks, Goldman Sachs, and Morgan Stanley, fueled concerns, accelerating the move lower.
Stronger-than-expected German data could help stem the sell-off. German factory orders rose 1.1% month on month in September, recovering from a 0.4% decline in August.
Meanwhile, the shows that activity in the service sector in October was stronger than expected, with output revised from the preliminary reading of 54.5 to 54.6. This marked the fastest growth in the sector in two years, supported by a notable increase in new business and contributing to the first rise in employment in the sector in 3 months. The , considered a good gauge of business activity, was also upwardly revised to 53.9. The level 50 separates expansion from contraction.
On the corporate front, Siemens Healthineer was the largest loser, dropping over 7% after posting Q4 revenue slightly below expectations, pressured by US tariff imports.
BMW is rising despite a decrease in earnings before tax to €2.3 billion, which contributed to a year-to-date figure of €8 billion. Vehicle deliveries rose by 8.7% year on year, with strong growth in Europe and the US.
After running into resistance at 24,635 in early August, the DAX has fallen further, breaking below the 50 SMA at 24,000 and spiking to a low of 23,580, which is the rising trendline support. The long lower wick suggests that there was little demand at the lower levels as dip buyers stepped in.
Buyers would need to rise above 24,000 to be on a more stable footing, bringing 24,400 into focus.
Sellers will need to break below yesterday’s low at 23580 and the rising trendline support. A break below here brings 23,400, the 200 SMA, and horizontal support into play.
USD/JPY is holding steady after yesterday’s losses, when the yen benefited from safe-haven flows amid the risk-off mood in the broader market.
However, today the picture has stabilised, suggesting that yesterday’s risk-off mood was more of a pause for breath rather than a decisive turning point.
Overnight, the minutes from the Bank of Japan meeting showed caution among board members due to the nation’s prolonged experience with deflation. The more dovish stance is limiting any upside in the yen.
While safe-haven plays have supported the yen, the also rose against its major peers yesterday on the same trade.
The US dollar trades at multi-month highs against its major peers, supported by declining bets on near-term Federal Reserve amid deep divisions among Federal Reserve board members.
Investors and policymakers are contending with a record-long government shutdown, which means U.S. economic data is scarce. As a result, more attention than usual will be on the private ADP payrolls later today, which is expected to show 25,000 jobs after -32k last month.
will also be in focus and as expected to rise to 50.8 up from 50 in September. Stronger data could help lift the US dollar, boosting USD/JPY.
USD/JPY trades in a rising channel. The price rose to an 8-month high of 154.50 in late October, hitting the upper bound of the rising channel before easing back to test 153.00, the October 9 high. The bullish trend is still intact. Buyers will look to rise above 154.50 to create a higher high, bringing 155 into focus ahead of 156.75.
Sellers will need to break below 153.00 to open the door to a deeper selloff towards 151.